Next Generation Partners

Firms To Watch: Healthcare and life sciences

Barnea Jaffa Lande & Co.'s growing client list includes a mix of local and international pharmaceutical, biotechnology and medical device companies.
Gornitzky & Co.  has a strong focus on handling IP and tech matters for global companies and start-ups.

Healthcare and life sciences in Israel

Arnon, Tadmor-Levy

A strong list of US-based international pharmaceutical companies entrust Arnon, Tadmor-Levy to undertake corporate, IP licensing, and financing as well as representation before the Israel Innovation Authority. Barry Levenfeld handles M&A and funding for both established companies and start-ups alike. He works alongside Daniel Green, a specialist in corporate partnering and IP, and Yoheved Novogroder-Shoshan, an expert in contractual licensing structures, and database and privacy. Miriam Friedmann advises on IP, licensing, privacy, commercial and corporate matters, and represents her clients before the Israeli Innovation Authority. Considered ‘a brilliant lawyer and a real healthcare expert‘, Efrat Shapira-Orren serves as Chief Counsel and Head of Legal and Regulation for Assuta Medical Centers, and advises healthcare clients on tenders and infrastructure projects. Other names to note are Avital Bruker-Yamin, an expert in handling day-to-day affairs in healthcare regulation, data protection and privacy, as well as transactions, and Avi Farchi, who specialises in clinical research trials and serves on several ethics committees in both private and public hospitals.

Other key lawyers:

Daniel Green; Yoheved Novogroder-Shoshan; Barry Levenfeld; Efrat Shapira-Orren; Joeri Kreisberg; Tamar Tavory; Miriam Friedmann; Tali Har-Oz; Avi Farchi; Avital Bruker-Yamin

Testimonials

‘Super professional team updated with broad topics regarding the health industry.’

‘Efrat Shapira-Oren is a brilliant lawyer with lots of knowledge, especially in the healthcare industry.’

‘A very talented team, with very unique expertise of the healthcare market and the entire healthcare-related legal practice. They provide full-scale coverage of legal consulting on the entire activity of our group of hospitals and medical centers, providing high quality and very professional service. The healthcare team is supported by the firm’s other departments when their expertise is needed, securing high quality and professional treatment of all legal issues.’

‘Efrat Shapira-Orren is an integral part of the group’s management and covers the full spectrum of our business. I consider her as a standout brilliant lawyer, a real healthcare expert, with analytic thinking, high creativity, deep business and economic understanding and very high managerial capabilities. A real asset to our group. Her knowledge, legal and business capabilities, creativity and understanding of the entire healthcare market stand out also when compared to other external or internal lawyers in the healthcare field.’

‘I work with Tadmor-Levy for several years and I am very satisfied. I worked with several lawyers and their personal and professional level is outstanding. As a team they are very responsive, and services-oriented – they always meet the deadlines and deliver excellent work. One more thing that I like about them is that when dealing with a legal issue, they are very active and try to present several possible solutions and help me understand what is the best fit for me. Generally speaking, I feel that I am in good hands and they protect my interests. They are also fair and efficient with respect to billing. I feel they make good use of the time they spent on the project.’

‘The firm is excellent and provides excellent, professional and sympathetic service.’

‘Leading office. Efrat Shapira provides excellent and professional service. In-depth knowledge of the relevant issues.’

‘Strong legal and business understanding, knows the company’s operation and Board of Director to streamline the legal process of any activity.’

Key clients

FutuRx

Alma Lasers Ltd.

Nym Health Ltd.

Switch Health Ltd.

Oramed Pharmaceuticals

Boston Scientific Corporation

Dentsply Sirona Inc.

Fosun Health Fund (the venture capital arm of Fosun Pharma)

Altaris Capital Partners, LLC

Assuta Medical Centers Ltd.

Assuta Ashdod Ltd.

Incentive Incubator Ltd.

SAREL Supplies & Services for Medicine Ltd.

Sinusafe Medical Ltd.

Allergan Plc

Stryker Corporation

Super Spectra

Alpha Bio Tec. Ltd.

Endomatic Ltd.

Medison Pharma Group

Heracure Medical

Bio Refine Ltd.

Work highlights

  • Advising Boston Scientific on its acquisition of the global surgical business of Lumenis.
  • Acting for FutuRx in IP licensing transactions, ongoing R&D, IP licensing and commercialization activities, services agreements, consulting agreements, research agreements, material transfer agreements, patent-related agreements and other agreements relating to technology research, development and evaluation.
  • Advising Altaris Capital partners on the acquisition of Perrigo Company Plc’s prescription pharmaceuticals business, with manufacturing facilities, material contracts and approximately one thousand employees.

Goldfarb Gross Seligman

At the forefront of cutting-edge healthcare and life sciences, the practice at Goldfarb Seligman & Co.has unique expertise in highly-regulated niche areas such as medical cannabis and Femtech, regularly advising innovative start-ups alongside its established, mostly domestic clientele on the whole range of work including corporate, commercial and financing transactions, and regulatory matters. Industry-reformer Sharon Gazit co-heads the practice together with Ashok J. Chandrasekhar and Zvi Bar-Nathan. Furthermore, Gazit leads the firm’s LegalTech innovation program ‘GS Lab’; has renowned proficiency in complex cross-border transactions and strategic investments; and serves as the co-chair of the Healthcare and Life Sciences Law Committee of the Israeli Bar Association. Among the experts in her team are Judy Amidor, a specialist in transactions relating to technology commercialization, Roy Lieber who advises start-ups on capital and debt raising transactions, and associate Yael Edell Rozenman who handles licensing structures, medical regulation, privacy, and information security. Efrat Rayten has departed following an appointment to the Knesset.

Practice head(s):

Sharon Gazit; Ashok J. Chandrasekhar; Zvi Bar-Nathan

Other key lawyers:

Judy Amidor; Roy Lieber; Yael Edell Rozenman

Testimonials

‘Highly professional yet very attentive and customer oriented.’

‘Professionalism and attentiveness.’

‘They are on top of the life sciences growing market in Israel. As I hope you know, I find the most important attributes of a good attorney to be professionalism, understanding the needs of the client, and getting the deal done (efficiently and thoroughly), and those are the goals I always strive towards.’

‘Sharon Gazit is heading the life sciences as well as technology department. She is very experimented in M&As, intellectual property transactions in the hi-tech and life science fields and has a growing practice in privacy and data security. She is a very good manager and team leader. I frequently liaise with Sharon within the IBA healthcare & life sciences law committee that Sharon is co-chairing and she is a very competent chair.’

Key clients

Baring Private Equity Asia PTE. Ltd.

BrainsGate Ltd.

EarlySense Ltd.

Novo Nordisk A/S

ReWalk Robotics Ltd.

‘Lilach- Live and Die with Dignity’

The Israeli Medical Association

Magen David Adom In Israel

Maccabi Healthcare Services

Carestream Health, Inc.

AquafitIntimate Ltd.

National Insurance Institute of Israel

Anchiano Therapeutics

Itamar Medical Ltd.

Wize Pharma Ltd.

Breath of Life International Ltd.

Cannbit Ltd.

Menorah Insurance Company Ltd.

BeaconCure Ltd.

iNNOGING Medical Ltd.

Bio-Fence Ltd.

MEDX Xelerator

Cardiovalve Ltd.

Temi Global Ltd.

RealView Imaging Ltd.

Enzymit Inc.

Y&B Mother’s Choice Ltd.

Work highlights

  • Advising EarlySense Ltd. on contractual matters with healthcare and life sciences entities, and the sale of its monitoring technology to Hill-Rom for $30m.
  • Representing The Israeli Medical Association in a range of regulatory matters, copyright, commercial agreements and disputes.
  • Advising RealView Imaging Ltd. on investments, agreements, IP, and a FDA approval for marketing and distribution of its 3D medical imaging system.

Herzog Fox & Neeman

An anchor in Israel for multinational healthcare and life sciences companies, Herzog Fox & Neeman also represents the country’s largest healthcare funds, having special expertise in health insurance regulation, tenders, and providing commercial advice as well as in representation before the Capital Market Insurance and Savings Authority and regularly advocates before the government on behalf of medical organisations. Additionally, the firm handles IP licensing transactions and patent litigation, and positions itself at the forefront of medical cannabis regulation. Former Special Advisor to the Director-General of the Ministry of Health Zohar Yahalom handles regulatory matters and strategizing as well as incorporation, drug approval, and competition matters. Yahalom and Neta Dorfman-Raviv who advises on insurance and finance-related matters co-head the team. On the IP side of the practice, Dan Sharot handles licensing and commercial transactions regarding medical innovation.

Other key lawyers:

Dan Sharot

Testimonials

‘Practical and knowledgeable.’

‘Vast past experience and customer oriented.’

‘Herzog’s team has a vast knowledge and understanding of the healthcare industry and practice and provides practical to the point counseling.’

‘The team has an overall view of the client’s goals and aims and knows how to provide the best result using all of the legal tools available. They are creative and out of the box thinkers with a touch of Israeli natured tune.’

Key clients

Accenture

Adama

Assuta Ashdod

Assuta Medical Centers

Clal Insurance Company

Johnson&Johnson

Liveperson

Fundbox

Maccabi Health Services (HMO)

Magen David Adom

Meuhedet (HMO)

Novolog

Merck Serono

Eli Lilly Israel

GE HealthCare

Abbvie

Novo Nordisk

Philips Healthcare

Isotopia Molecular Imaging

Sahara Medic

Boehringer Ingelheim Israel

Teva

Wolt

Zimmer Biomet

Work highlights

  • Providing Magen David Adom with ongoing advice on regulatory, corporate, commercial, privacy protection, IP, and certain employment matters.
  • Providing ongoing advice to Eli Lilly and Boehringer Ingelheim on all regulatory matters.
  • Handling ongoing regulatory and commercial matters for Meuhedet related to the health insurance coverages it provides to its members as an insurer, and to its employees, doctors and officer as a policyholder and advising on pharmaceutical regulation and clinical trial agreements.

Horn & Co

A boutique firm recognised for its work in complex IP licensing mandates, Horn & Co also handles M&A and capital market transactions for both multinational companies in Israel and national clients abroad with particular expertise pertaining to the US market. The firm’s international reach is extended to the UK through the experience of Yuval Horn, who regularly advises on global transactions and in all other areas hi-tech and life science companies are active in. Additionally, he served as co-chair of the International Bar Association’s Technology Law Committee and represents the firm in the European legal network Biolegis. Keren Kanir is an expert on the intersection of corporate finance and IP, advising public and private companies as well as hedge funds in these matters. Ohad Mamann has left  for an in-house role.

Practice head(s):

Yuval Horn

Other key lawyers:

Keren Kanir

Testimonials

‘Yuval Horn and Keren Kanir would stand out in any law firm as super-sharp, problem solving-oriented and very efficient.’

Key clients

Pontifax VC

Zebra Medical Vision Ltd.

Vascular Biogenics Ltd.

Biosight Ltd.

Biolight Life Sciences Ltd.

Diagnostic Robotics Ltd.

MedAware Ltd.

Aposense Ltd.

Lutris Pharma Ltd.

Work highlights

  • Representing Zebra Medical Vision Ltd. in its acquisition by Nano-x, valued at $200m.
  • Represented Biosight Ltd. in the acquisition of Advaxis Inc.  

Lipa Meir & Co

Made up of veterans, with extensive experience not only in business but also in regulation‘, the team at Lipa Meir & Co advises on commercial agreements, joint ventures, data protection, licensing and related issues for the national healthcare sector and additionally handles class actions and civil actions as well as regulatory matters such as medical cannabis. One such veteran is practice head Gary Copelovitz who focuses on M&A transactions, innovative and disruptive technologies, and general corporate advice. Other names to note include Roy Aiz, a specialist in medical infrastructure investments and databases, and Meir Elbaum who handles tender and insurance matters.

Practice head(s):

Gary Copelovitz

Other key lawyers:

Roy Aiz; Meir Elbaum

Testimonials

‘The Lipa Meir team is an excellent group of professionals with experience not only in the private sector, and with no competition in the government, and with the Largest HMO in Israel. The team is made up of veterans, with extensive experience not only in business but also in regulation.’

‘Gary Copelovitz who runs the health tech team in Lipa is a true deal maker. With his vast knowledge, understanding and sound advice, he is not only helping you close the deal on the business side but also on the regulatory side.’

Key clients

Clalit Health Services

Lahav CRO

Galil Ofek Incubator

L.E.M. Laboratory for Early Detection

Laser Team Medical Ltd.

Mor Institute for Medical Data Ltd.

Mor-Mar Ltd.

Tel Hashomer Hospital

Shila Medical Services Ltd.

Mor Research Applications Ltd.

Medtechnica Orthophone Ltd.

Nevo Medical Ltd.

Natural Birth Center

Clal Insurance Company Ltd.

Tel Bar Industries For Health Institutions Ltd.

Nevo Robotica

Clalit Biomedical Engineering Ltd.

Taliaz

Kibbutz Alumim

Menora Mivtachim Holdings Ltd.

Blistex Inc.

Brosh Pharm Ltd.

Work highlights

  • Representing Mor Institute for Medical Data Ltd. in its acquisition of Herzliya Medical Centre.
  • Advised Clalit Health Services Ltd. on data sequencing, cyber protection, and compliance.
  • Acted for a natural birth centre and the Calling for Child Birth Movement regarding a judgement delivered by the Israeli Supreme Court.

M. Firon & Co Advocates and Notaries

Representation experience in Europe, Asia, and the US is reflected in M. Firon & Co Advocates and Notaries‘ diverse clientele which includes both foreign and domestic companies for which it covers various practice areas with notable expertise in M&A; it also advises start-ups during investment rounds and in regards to their licensing structures. Department co-head Baruch Shugol has notable expertise in the pharmaceutical and biotech industries and is a member of the Tel Aviv Sourasky Medical Center Institutional Review Board. Fellow team-leader Sivan Narkiss excels in regulatory matters.

Practice head(s):

Baruch Shugol; Sivan Narkiss

Other key lawyers:

Gail Etzion; Jacob Enoch

Testimonials

‘Amazing team, one-stop-shop, strategic thinking and execution, holistic thinking. Gail Etzion has a lot of experience which brings added value to each of the transactions we are involved in.’

‘This practice is unique due to the personal relationship our partner maintains with us and the deep understanding of our needs and challenges. Advice far exceed just legal aspects. The firm is very responsive and professional – a fact that leads to smooth dealing with fewer iterations.’

‘We work with Gail Etzion who leads the firm high-tech practice. Gail has been outstanding in terms of her professionalism and responsiveness and was key in addressing complex legal and business aspect. The fact she has outstanding interpersonal communication skills significantly helps deal to converge.’

‘Jacob Enoch – what can I say. The reason we came to Firon. Cannot imagine our business without him. Does all our transactions and supports all our commercial activities. So much more than a lawyer. I wish such a genius on every client. Truly unbelievable. Baruch Shugol – such experience and class. Always there to offer wise advice. So well know and respected.’

‘Easily the strongest healthcare team in the country.’

‘Jacob Enoch – brilliant multidisciplinary lawyer. Lots of healthcare experience on top of being recognized as one of the top M&A attorneys out there, and a first class litigator. Baruch Shugol – a veteran first rate professional. Possibly the most prominent healthcare attorney in Israel. Knows everyone, has seen everything, can tackle any problem. Sivan Narkiss – Nest gen super star.’

‘M. Firon is there for us for any legal matter of significance. From Negotiations towards the sale of the company (and other corporate matters, ESOP and more), through all commercial agreements and up to all our licensing agreements. First-class and top-notch all the way.’

‘Jacob Enoch – knows our business inside out. Multi-faceted wizard. One of a kind. Makes deals happen, employs out of the box creative solutions, and is truly irreplaceable for us. Baruch Shugol – Has seen it all. Has done it all. Best Israeli attorney in the healthcare arena.’

Key clients

Gilead

Ferring

Tel Aviv Sourasky Medical Centre

Clalit Health Services

Pharma Israel

Sanofi

EMMS Nazareth Hospital

Hadassah Medical

Herzliya Medical Centre

S.L.H. Medical Services Ltd.

Guangzhou Sino-Israel Bio-industry Venture Capital Investment Fund

CorNeat Vision

DMC

Geffen Medical

Novolog

Work highlights

  • Advising Pharma Israel on dealing with the Ministry of Health regarding regulation in the field of pharmacy and responding to procedures.
  • Acting for Sanofi in a range of clinical trials, privacy, competition and regulatory matters.

S. Horowitz & Co

S. Horowitz & Co advises clients across the entire spectrum of the life science industry on a range of commercial transactions, class actions, and IP issues, most notably the commercialisation of patents, and has strong regulatory expertise evidenced by the firm acting as legal counsel during the legislative process of the Medical Devices Law. Co-head Dovev Apel is a seasoned litigator in IP and handles product liability and class actions. Apel leads the team with Tal Band, who focuses on administrative litigation before all judicial instances as well as the Patents and Trademarks Office and previously served as President of the Israel Chapter of the AIPPI.

Practice head(s):

Tal Band; Dovev Apel

Other key lawyers:

Asaf Rentsler; Moran Katz; Yair Ziv

Key clients

Teva Pharmaceutical Industries Ltd.

The Chemical, Pharmaceutical and Environmental Society of the Manufacturer’s Association of Israel

Maccabi Healthcare Services

Procter & Gamble Israel Ltd

Dexcel Ltd. and Dexcel Pharma Technologies Ltd.

Novocure Inc.

Hadassah Medical Organization

Allergan Inc.

Indena S.p.A.

Forever Living Products (Israel) Limited

Taro Pharmaceutical Industries Ltd.

Genmab A/S

Medial Group

Santhera Pharmaceuticals

Yeda Research and Development Limited

Oxygnium

I.S.R – The Institute for Skin Research

Zimmer Biomet

Takeda Pharmaceutical Company

Sanofi Aventis

Galmed International Ltd.

Hadasit Medical Research Services and Development Ltd.

Advanced Oncotherapy plc.

Solomon, Levine, and Elstein Ltd.

8679410 CANADA INC.

Simplivia Healthcare ltd.

Tel Aviv University

M.I.P Veterinary ltd.

Euromar Ltd.

Amgen Inc.

Rhenium research laboratory equipment Ltd.

Alpa Cosmetics

K.I. Research Institute (R.A.)

Work highlights

  • Representing Teva Pharmaceutical Industries Ltd. in a dispute with Abbot Israel regarding the alleged use of fictitious profiles and paid commenters on social media for the promotion of the Similac brand and negative influence on the sales of Teva’s Nutrilon brand.
  • Represented Sanofi in a highly complex motion to certify a NIS 1.5 billion (USD 450 million) class action concerning the alleged lack of information on its Patient Information leaflet of Sanofi’s product indicated for insomnia.
  • Representing Euromar in an additional petition that was filed with the Supreme Court (sitting as the High Court of Justice) by A. Bee-Zee Consultation and Marketing Ltd, concerning the registration procedure for a veterinary preparation directed to the treatment of intestinal diseases of poultry.

Agmon with Tulchinsky Law Firm

The team at Agmon with Tulchinsky Law Firm, which is the result of a December 2022 merger between Agmon & Co. Rosenberg Hachohen & Co. and Tulchinsky Marciano Cohen Levitski & Co, handles IP licensing and technology transfers, litigation, class actions and cross-border M&A transactions. The team is jointly led by David Cohen who also advises on public and private financing mandates and Uri Barak who handles commercial and corporate finance transactions.

Practice head(s):

David Cohen; Uri Barak

Other key lawyers:

Alon Tabak-Aviram; Gershon (Glenn) Shalom-Winter; Tamar Nesher

Key clients

Teva Pharmaceutical Industries Ltd.

Minovia

Neuroderm

The National Institute for Biotechnology

RedHill Biopharma Ltd.

ConTIPI Medical Ltd.

Haldor

Biond Biologics

RA Capital

Widex

Work highlights

  • Advising Biond Biologics Ltd. on the development and commercialization of a novel cancer treatment.
  • Acted for RedHill Biopharma on the termination of a license agreement with Salix Pharmaceuticals Ltd. and the regaining of the worldwide exclusive rights to RHB-106.
  • Advised Luneau Technology in its acquisition of a California-based company – Optovue Inc. via a reverse-triangular merger.

Amit, Pollak, Matalon & Co. Advocates and Notary

A strong expertise in representing investors in the healthcare and life sciences sector, particularly in the highly regulated matter of medical cannabis, characterises the practice at Amit, Pollak, Matalon & Co. Advocates and Notary. Recent highlights also saw the team assisting hi-tech and start-up companies with the commercialisation of their IP and represents them before the Israeli Innovation Authority. Co-head Ian Rostowsky is an expert in M&A and venture capital transactions. Yoav Etzyon focuses on representing public and private companies on a range of transactions, notably in equity and debt offerings, with an international scope as he is qualified in both Israel and New York. Outside the department, he serves as the vice chairman of the High Tech Committee of the Israeli Bar Association. Ran Cohen has been promoted to the partnership, and welcomed Sahar Peled and Omer Carmel have joined from Carmel, Peled & Co., Law Office alongside Itamar Cohen who departed from Zysman, Aharoni, Gayer & Co (ZAG-S&W). Gal Omer departed for an in-house role.

Practice head(s):

Ian Rostowsky; Yoav Etzyon

Other key lawyers:

Chagit Pedael Levin; Stephen Barak Rozen; Dr Tal Tirosh; Hilla Shribman; Elinor Polak; Itai Nachtomy

Key clients

Nanox Imaging Ltd.

Motus GI (NASDAQ: MOTS)

KeepMed Ltd.

aMoon Fund

aMoon Velocity Fund

MindUP Ltd.

Novartis International AG

Panaxia Pharmaceutical Industries Ltd.

Epitech Mag Ltd.

Xinteza API Ltd.

Human Mission Inc.

DermaFence Ltd.

F.O.R.E Biotherapeutics Ltd

Chemo Group/Exeltis

Orsense Ltd.

DVC-Pro

APX Ophthalmology Ltd.

TearFlow Care Ltd.

Healeon Medical Ltd.

MindUP Ltd.

Meridian Bioscience, Inc.

CanNegev Ltd

NovaSight Ltd Dali Medical Devices Ltd.

Work highlights

  • Advised Nano-X Imaging Ltd. on its initial public offering on Nasdaq for a capital raising in excess of US$125m.
  • Advised Ilumigyn on a mix of financing, commercial and IP-related matters.
  • Advising KeepMed on its $12.6 million Round C  equity financing by an affiliate of Merieux Equity Partners, French Venture Capital Funds, Pitango Ventures, Xenia Venture Capital and leading industry KOLs.

FISCHER (FBC & Co.)

Large international pharmaceutical companies instruct FISCHER (FBC & Co.) on M&A transactions, IP licensing, technology transfers, and regulatory matters. The department is jointly led by Raz Tepper who acts for medical and biotechnology companies and venture capital funds, and Eran Yaniv, an expert in cross-border and venture capital transactions. Their team also includes Shmulik Fried and senior associate Warren Wienburg, both handle a broad range of commercial matters. Recently-promoted partner Ute Klose-Goldstein advises on venture capital and M&A transactions, often with a cross-border element.

Practice head(s):

Raz Tepper; Eran Yaniv

Other key lawyers:

Shmulik Fried; Warren Wienburg; Ute Klose-Goldstein

Testimonials

‘Business oriented approach, can back you up in most disciplines , wide network also international.’

‘Raz Tepper is supper professional, easy to work with, smart, and very experienced.’

‘I enjoy working with the legal team, and I learn from them quite a lot. While I am not fully immersed in legal terms and business/investments vehicles, I receive from the team clear explanations, analyses and alternatives options to choose from. They are very pro-active in diffusing potential future complications with investors and among shareholders in general. I feel I have a legal and business companion accessible to me at any given moment.’

‘At the end of the day, it all boils down to generating a friendly environment, without compromising on the deliverable. The partners I work with at the firm are are approachable when needed, even long after the end of the working hours – so it makes it easier to discuss burning issues when needed rather quickly. I know exactly that I will not look around for other lawyers.’

Key clients

Perrigo

Kamada Ltd.

Sandoz AG

AstraZeneca

Glaxo Group Limited

GlaxoSmithKline Intellectual Property (GSK)

Alexion Pharmaceuticals

Viola

Purple Biotech

CytoReason

415 Capital

Blumberg VC

Metasight Diagnostics

Peregrine

OrbiMed Healthcare Fund

Rainbow Medical Ltd.

Abbott – St. Jude Medical

Hadassah Medical Organisation

Adicet Bio Ltd.

Allium Medical

Alpha-Bio Tech Ltd.

American Well Corporation

Bristol-Meyers Squibb Company

Meuhedet Health Fund

Check Cap Ltd.

MetaboMed Ltd.

Motus G.I.

NanoSpun Technologies

Nano Retina Ltd.

Nutrinia

Octopus Ventures

Pangea Therapeutics Ltd.

Pythagoras Medical Ltd.

Real Imaging Holdings Ltd.

Work highlights

  • Advising Perrigo Company Plc on the sale of Perrigo’s Generic Rx Pharmaceuticals business to Altaris Capital Partners, LLC for $1.55bn, and in a class action.
  • Advised Kamada Pharmaceuticals in IPOs and investments,  and advising on regulatory compliance, privacy and data protection, licensing, and commercial agreements
  • Acted for AstraZeneca Plc in the $39bn acquisition of Alexion Pharmaceuticals Inc.

Gross Law Firm – GKH

Gross Law Firm – GKH ‘s client roster features start-up and well-established global companies which it advises on transactions including licensing, technology transfer, funding, and regulatory matters.  Hili Cohen handles compliance and regulatory matters as well as corporate and commercial transactions, and Tami Fishman Jutkowitz excels in private financing, M&A, technology transfer and licensing.

Practice head(s):

Hili Cohen;Tami Fishman Jutkowitz

Key clients

3 Millenium Group

Accelmed

AIVF

Align Technology, LTD

Almeda Ventures Limited Partnership

American Well

Arkin Holdings

Atricure

BactoByte

Best Brain

BeyondMeat

Bioforum

BiondVax

BionTech

Bio Meat

Brainsway

Biogen

Bunge

Cannopiea

CLAL Biotech INDUSTRIES LTD

ClearSkin Ltd.

Collplant

Cookin

Covington & Burling

Cronos Group

Edwards Lifesciences Corporation

eHealth Ventures

Elanco

Endospan

Enveric Biosciences, Inc.

Eximo Medical Ltd.

GI View Ltd.

Hogan Lovells

Heally IL Ltd.

Igentify Ltd.

Industrie Biomediche Insubri SA

InMed

InnoBev Ltd.

InnovaHealth Partners

Inovytec Medical Solutions

Insightech

Intratech Medical

Invisicare

Invitae

Izun Pharma

Keystone Dental Inc.

Madrigal Pharmaceuticals

Magenta Medical Ltd.

MDGO Ltd.

MDI Health Technologies.

MDigo

MedCPU

MediMe.

Medtronic

Milagro

Morrison & Foerester

Mother’s Choice

MSD

My Ukko

NeuroSense Therapeutics

opticaldiagnostics.com

Organigram

Ortho Clinical Diagnostics

Osborne Clark

Petsapien.

Pharmaceutical Research Associates (PRA)

PRA HealthScience.

Premier Research

Providence Health & Services

Pulsemore

Q-Art Ltd.

Rainbow Medical Ltd

Rapid Medical Ltd

Redhill Biopharma Ltd

Respiration Scan

Rimonim

SciVac

SeeGene

SheRun Labs Ltd.

Sol-Gel Technologies Ltd

Sonivie Ltd

Spatz FGIA

Sufresca

Telesofia Medical Ltd

Therapix Biosciences Ltd

Under Pressure

Valcare

Vibrant Ltd

VRHealth

Well Beat

WellBeat Ltd

West Pharmaceutical Services, Inc.

Yissum Research Development

Zimmer Biometz

Work highlights

  • Advised Providence Healthcare & Services in its first investment in an Israeli company – TailorMed Ltd.
  • Advised Sol-Gel on a licensing transaction with Galderma for the commercialization of EPSOLAY® and TWYNEO® in the United States.

Liad Whatstein & Co. Law Office

IP litigation is the heart of boutique firm Liad Whatstein & Co. Law Office; its additional proficiency in regulatory matters alongside experience in pharmaceutical technology, R&D agreements, and joint ventures make it popular choice for the State of Israel and a long list of large international pharmaceutical companies. Liad Whatstein is one of Israel’s leading IP litigators, recently representing Pfizer in an appeal before the Supreme Court regarding patent infringement proceedings against Unipharm for the well-known drug VIAGRA. Amira Mangelus who is a seasoned patent litigator is also a key name to note.

Practice head(s):

Liad Whatstein; Amira Mangelus

Other key lawyers:

Oren Weiner

Testimonials

‘Liad is an exceptional lawyer, and his firm is first rate.’

‘Liad Whatstein & Co has a great understanding of the Israeli law and provides excellent strategic advice. The team has great technical understanding of the subject matter and writes excellent detailed briefs. It also makes pragmatic advice in running life sciences projects. They have embraced technology since the start of the pandemic and that has helped to provide seamless advice despite being unable to have face-to-face meetings.’

‘Liad Whatstein is a stand out individual. His in-depth understanding of the law together with technical understanding of the science allows him to give very pragmatic advice. Liad is also very responsive and the work product is excellent.’

Key clients

Novartis

Merck

AbbVie

Pfizer

The State of Israel

Sanofi

Eli Lilly

Leo Pharma

Pharma Israel

Regeneron

Purdue/MundiPharma

Lundbeck

Abbott

Dr. Fischer Pharmaceuticals

Novo Nordisk

BMS

Alkermes

Genzyme

Takeda

Advanced Accelerators Applications

InterMune

Work highlights

  • Representing Novartis in several patent proceedings relating to blockbuster drugs such as Afinitor and Revolade, cancer cell proliferation, and synthetic organic chemistry.
  • Representing Sanofi and Regeneron in opposition proceedings against Amgen relating to the parties’ antibody drugs Praluent and Repatha.
  • Advising Merck, Sanofi, and Novartis on regulatory aspects of drug approval and data protection in Israel.

Meitar law offices

Holistic in its approach, Meitar Law Offices' broad practice handles IP, clinical trials, product liability, and M&A for a long list of life sciences companies and healthcare institutions. Within the team, Haim Gueta handles restructurings, joint ventures, debt and equity financing and cross border M&A transactions; Boaz Mizrahi has notable expertise in licensing and collaboration transactions, and Ron Peleg focuses on product liability, class action, and regulatory matters.

Practice head(s):

Haim Gueta; Boaz Mizrahi; Ron Peleg

Other key lawyers:

Michael Weiner; Shay Reiner; Daniel Colthof

Testimonials

‘Very knowledgeable, highly professional, down-to-earth people. I most appreciate the accessibility and virtual contact options. Work is done in the most cost-efficient manner (staffing) and yet maintains professional output.’

‘Ron Peleg is always accessible, always open to feedback, highly knowledgeable in the subject matter. Advice is given in a practical manner.’

‘The biotechnology practice of Meitar and especially Mr. Boaz Mizrachi our long term point of contact at the firm provides a good service to its Israeli clients, the firm is both international and local, and with especially good knowledge of the local and global regulations, is practical in its approach, easy to work with and friendly and available and responsive.’

‘Mr. Boaz Mizrachi has been our point of contact at the firm, his quality advice, personal understanding of our needs and personality as well as his ability to take part in commercial / contracts negotiations and day to day discussion vis a vis regulatory bodies in an amicable but direct and clear way make him a good practical legal advisor.’

Key clients

InspireMD

Medison

Alpha Tau

Gamida Cell

Ayala Pharmaceuticals

Mediwound

Senseera

Bayer

Mylan

Eli lilly

Pfizer

Galmed

Mapi-Pharma

Medtronic

AstraZeneca

Bristol-Myers Squibb

GlaxoSmithKline

Pharma Two Be

Stem Cells Medical

ChemomAB Ltd.

Tera Novel

ImmunAI

Magentiq Eye

Medicane Research and Development

Medigate

Ela Pharma

Phenomed Ltd.

Ikko Health Ltd.

Embryonics Ltd.

Causalis.AI Ltd.

Biokine Therapeutics

Genetikaplus

Kadimastem

Aidoc

EZbra Advanced Wound Care

Elastimed

Merck

Eisai

Novartis

Celgene

Work highlights

  • Acted for Lumenis Ltd. in the sale of its surgical business division to Boston Scientific Corporation, valued at $1.07bn.
  • Advised Gamida Cell Ltd. in the issuance of funds affiliated with Highbridge Capital Management and two public offerings.
  • Advised SURE Universal, a company developing IoT software for home healthcare, in a transaction with UAE’s HBK Department of Projects (HBK DOP) to launch the “HBKiCare” product, a white label smart IoT healthcare solution, for both the UAE and the Middle East regional markets.

Pearl Cohen Zedek Latzer Baratz

Leveraging its impressive international footprint with offices in the US,  Europe, the UK, and Asia, Pearl Cohen Zedek Latzer Baratz is best placed to assist US and domestic pharmaceutical, medical cannabis, tech transfer companies and healthcare start-ups on IP, corporate law, securities, and employment matters. It handles a steady flow of contentious and non-contentious patent matters which the firm particularly excels. Managing partner Zeev Pearl is recommended for IP portfolios, licensing, litigation, and commercial transactions.  Co-head Mark S. Cohen focuses on patent prosecution and licensing transactions. Yael Baratz also jointly heads the team, and is recommended for licensing, technology licensing and collaborations, and M&A transactions.

Practice head(s):

Zeev Pearl; Mark Cohen; Yael Baratz

Other key lawyers:

Hili Rashkovan; Inbal-Perlstein-Mandelbaum; Ephraim Heiliczer; Dotan Hammer

Testimonials

‘The team was very professional in any topic we needed assistant in, being responsive, fully transparent and clear with the legal procedures we needed to go through. The entire office worked together creating a very efficient and agile team compared to law firms we have used before, giving excellent service in an excellent response time. The team helped a lot in promoting the legal process of the company and organizing it for us.’

‘The cross border team we are working with (Zeev Pearl and Dotan Hammer), professionals in both the US and in Israel, are a powerhouse of IP knowledge, legal quality work and unrivalled customer service. They are top-notch experts in their field and have always provided valuable legal advice and guidance. They are very strategic, business oriented and take the time to fully understand our business, products and goals. Their service is outstanding. I would recommend any technology company to the team at Pearl Cohen.’

‘The Individuals we worked with from the firm were just exceptional. They provided great service, in an efficient way, saving us a lot of time. The work was done while keeping the good spirit, while presenting in a clear manner the legal issues and the needed procedures in a very clear and simple way, giving us the ability to make the right strategic decisions.’

Key clients

Bayer AG

Opko Health Ltd.

Pfizer Inc.

Sanofi S.A.

Orgenesis Inc.

Dexcel Pharma

Panaxia Pharmaceutical Industries Ltd

Maccabi Health Services

Biondvax Pharmaceuticals Ltd.

Ayala Pharmaceuticals

Verliy Life Sciences

SciVac Ltd.

KAHR Medical Ltd.

Ascend Performance Materials

Estar Medical

Amoon Fund

Nobio Ltd

Work highlights

  • Acting for Bayer AG and its subsidiaries in IP, regulatory, and corporate matters.
  • Advised Orgenesis and its Israel and global subsidiaries on the full scope of M&A, commercial, corporate and IP services, including the formation of a strategic partnership with Great Point Partners, LLC.
  • Advising Dexcel, on a range of corporate and IP matters.

Shibolet & Co.

A strong focus on hi-tech and start-up companies and an international scope with offices in the US and China characterise the practice at Shibolet & Co.  The team focuses on venture capital work and handling cases relating to funding and commercialisation of the funded technology as well as the grant of relevant rights before the Israeli Innovation Authority. Ofer Ben-Yehuda advises on corporate and cross-border transactions, as does Einat Weidberg who also specialises in debt financing matters. Yoav Manor has recently been promoted to the partnership.

Practice head(s):

Ofer Ben-Yehuda; Einat Weidberg

Other key lawyers:

Tal Karplus; Amir S. Iliescu; Maya Koubi Bara-nes; Yoav Manor; Daniel Kariv; Effy Stern

Key clients

Technion Research and Development Foundation Ltd.

Technion Investment Opportunities Fund

Ancora Medical

CartiHeal (2009) Ltd.

ApiFix Ltd.

RDD Pharma Ltd.

Compugen Ltd.

The Trendlines Group Ltd.

NovoCure (Israel) Ltd.

Elron Electronic Industries Ltd.

Alon Medtech Ventures Ltd.

BeyeOnics Surgical Ltd.

OrthoSpin Ltd.

BIG Shopping Centers

Jafora-Tabori

Rafael Advanced Defence Systems

Israel Railways Ltd.

Nizat HaDuvdevan

Arad Group

Ifat Group

Mifal HaPais

Commercial Radio Stations Association

ELECTRA Group

IACIE – Israeli Association of Construction & Infrastructure Engineers

Israel Ports Developments & Assets Company

BIG Shopping Centres

Work highlights

  • Advising Sofwave on its successful IPO and listing on the Tel Aviv Stock Exchange.
  • Advising PulseNmore Ltd. on raising USD 14 million in pre-IPO and in its successful IPO and listing on the Tel Aviv Stock Exchange.
  • Advising Aviv Scientific, a world leader in improving brain performance and treating the aging process via personalized pressure cell treatments, on a US$22 million investment transaction (Round A) made by Danel Ltd.